Announcing The Penn Institute for RNA Innovation
The Penn Institute for RNA Innovation is a new institute dedicated to the understanding and development of all aspects of RNA from basic to translational science.
Katie Reuther on The Future of Penn Health-Tech and Penn’s Thriving Innovation Ecosystem
Penn Health-Tech is well known for turning innovative ideas across the health system into useful technologies and products that solve problems and advance health care.
Penn Gene-Editing Spinout iEcure Receives Rare Pediatric Disease Designation from FDA for Lead Drug Candidate
iEcure is developing the new drug candidate, GTP-506, as a treatment for a rare genetic condition caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia.
Carl June Discusses Applications of CAR-T Cell Therapy in Science Friday Interview
In this Science Friday interview, Dr. Carl June discusses CAR-T's continued use in battling new blood cancers, as well as its future potential for treating solid state cancers and autoimmune diseases.
Penn-invented CAR-T Therapy Achieves Unprecedented Milestone
"We have a couple dozen patients who are 5, 6, 7, 9 years out or more without further therapy. That feels like a cure to me."
Penn Spinout REGENXBIO Inc. Enters Commercial Phase; Focuses Gene Therapy on Common Cause of Blindness
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
Three Penn Medicine Innovation Projects Receive Clinical Care Innovation Grants from Independence Blue Cross
Learn about these cutting-edge new projects that are improving value-based medical care.
Penn Medicine Ranks on List of Top US Health Systems by Merative and Fortune
Penn Medicine ranked number two out of the top five large health systems, second only to Mayo Clinic in Rochester, MN.
Philadelphia-based Cancer Research Institutions Receive over $700M in National Cancer Institute Grants from 2019 to 2021, Fourth-most in the Nation
The University of Pennsylvania led the region with 490 NCI grants totaling $234 million during this three year time period.
Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors
Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.